Parallel Advisors
EBS icon

Parallel Advisors’s Emergent Biosolutions EBS Stock Holding History

Parallel Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.78K Buy
270
+249
+1,186% +$1.64K ﹤0.01% 3667
2026
Q2 		$176 Buy
+21
New +$176 ﹤0.01% 3857
2024
Q1 		– Sell
-62
Closed -$149 – 3331
2023
Q4 		$149 Hold
62
– – ﹤0.01% 3200
2023
Q3 		$211 Sell
62
-33
-35% -$183 ﹤0.01% 3222
2023
Q2 		$698 Buy
95
+18
+23% +$167 ﹤0.01% 3023
2023
Q1 		$798 Hold
77
– – ﹤0.01% 3007
2022
Q4 		$909 Buy
77
+15
+24% +$232 ﹤0.01% 2921
2022
Q3 		$1K Buy
62
+35
+130% +$974 ﹤0.01% 2887
2022
Q2 		$1K Sell
27
-22
-45% -$751 ﹤0.01% 2744
2022
Q1 		$2K Sell
49
-153
-76% -$6.75K ﹤0.01% 2560
2021
Q4 		$9K Buy
202
+176
+677% +$7.96K ﹤0.01% 2147
2021
Q3 		$1K Sell
26
-24
-48% -$1.45K ﹤0.01% 2843
2021
Q2 		$3K Buy
50
+45
+900% +$2.89K ﹤0.01% 2447
2021
Q1 		$0 Sell
5
-16
-76% -$1.64K ﹤0.01% 2817
2020
Q4 		$2K Buy
+21
New +$1.93K ﹤0.01% 2293
2020
Q3 		– Sell
-10
Closed – – 2579
2020
Q2 		$0 Buy
+10
New +$745 ﹤0.01% 2504
2020
Q1 		– Sell
-114
Closed -$6K – 2435
2019
Q4 		$6K Hold
114
– – ﹤0.01% 1901
2019
Q3 		$6K Sell
114
-114
-50% -$5.31K ﹤0.01% 1850
2019
Q2 		$11K Hold
228
– – ﹤0.01% 1546
2019
Q1 		$12K Hold
228
– – ﹤0.01% 1442
2018
Q4 		$13K Sell
228
-6
-3% -$387 ﹤0.01% 1214
2018
Q3 		$15K Buy
+234
New +$13.7K ﹤0.01% 1263

Other funds holding EBS

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Values First Advisors
Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
SummerHaven Investment Management
SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
James Investment Research
James Investment Research Alpha, Ohio $936M AUM 24.49% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parallel Advisors's EBS Position: Q3 2026 in Review

Parallel Advisors increased its Emergent Biosolutions (EBS) stake by 1,186% in Q3 2026, buying an estimated $1.64K and bringing the position to 270 shares worth $1.78K. The position accounts for ﹤0.01% of the portfolio, ranked #3667.

Parallel Advisors first reported a position in EBS in Q3 2018 and has held it in 22 quarters since. The position peaked at $15K in Q3 2018. 51 funds tracked by Wall St. Rank hold EBS as of Q3 2026.

  • Parallel Advisors held 270 shares of Emergent Biosolutions worth $1.78K as of Q3 2026.
  • Parallel Advisors bought 249 Emergent Biosolutions shares in Q3 2026, an estimated $1.64K.
  • Emergent Biosolutions made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3667 holding.
  • Parallel Advisors first reported a position in Emergent Biosolutions in Q3 2018 and has held it in 22 quarters since.
  • Parallel Advisors's Emergent Biosolutions position peaked at $15K in Q3 2018.
  • 51 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.